Press Release NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
Press Release NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress
Press Release NeonMind Announces Closing of Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option
